GlassScriptPhysician profile
Mauricio Cohen
NPI 1386717114
$129,444.38
in general payments reported to CMS, 2019-2025
36 companies · $25K in 2025
The $25K reported for 2025 was more than what 94% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $11K · 2021: $8,818 · 2022: $20K · 2023: $13K · 2024: $14K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Food and Beverage: $6,795 · Travel and Lodging: $5,256 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Honoraria: $1,200 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,067.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Food and Beverage | $6,794.67 |
| Travel and Lodging | $5,255.96 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Honoraria | $1,200.00 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33,941.89 | 2019-2025 | Vantageview, Navitor, Freestyle Libre |
| Boston Scientific Corporation | $17,697.15 | 2019-2025 | General - Vascular Access, Clinical Trial Product, Watchman Flx |
| Medtronic Vascular, INC. | $14,716.30 | 2019-2020 | |
| Abiomed | $11,861.63 | 2019-2022 | |
| Cordis US Corp. | $10,293.36 | 2021-2025 | Emerald, Selution Slrptca, Mynx Control |
| Edwards Lifesciences Corporation | $9,011.01 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Evoque, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merit Medical Systems INC | $8,112.00 | 2019-2021 | |
| Terumo Medical Corporation | $5,969.49 | 2020-2024 | Angio-Seal, Glidewire |
| Astrazeneca Uk Limited | $4,054.96 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $3,000.00 | 2019 | |
| Medtronic, INC. | $2,272.18 | 2021-2025 | Corevalve Evolut R |
| Ancora Heart, INC. | $1,629.90 | 2021 | |
| Inspiremd LTD | $1,381.00 | 2022-2024 | Cguard, Cguard |
| Asahi Intecc USA, INC. | $1,267.79 | 2021-2025 | Asahi Coronary Wires, Peripheral Vascular |
| Astrazeneca Pharmaceuticals LP | $1,188.84 | 2019-2025 | Wainua |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $734.03 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $572.10 | 2022-2024 | Indigo System |
| Teleflex LLC | $268.46 | 2022-2025 | Guideliner |
| Philips North America LLC | $176.45 | 2022-2024 | (Cm9) Amb Mon & Diag Und |
| Stryker Corporation | $173.77 | 2023 | Na |
| Osprey Medical INC | $161.25 | 2020 | |
| Zoll Circulation INC | $147.60 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Cardiva Medical, INC. | $124.15 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Dilon Technologies, INC. | $121.20 | 2024 | Hemoblast Bellows |
| Angiodynamics, INC. | $93.82 | 2019-2022 | |
| Procyrion, INC. | $88.19 | 2023-2024 | Aortix System |
| Opsens INC. | $78.55 | 2020 | |
| Alnylam Pharmaceuticals INC. | $44.32 | 2024-2025 | Onpattro, Amvuttra |
| Cleerly, INC. | $43.18 | 2025 | Cleerly Labs, Cleerly Ischemia |
| W. L. Gore & Associates, INC. | $42.98 | 2023-2025 | Gore Cardioform Septal Occluder |
| Inari Medical, INC. | $42.96 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ethicon US, LLC | $42.12 | 2021 | |
| Amgen INC. | $35.60 | 2023-2025 | Repatha |
| Heartflow, INC. | $29.84 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $26.31 | 2024 | Arcalyst |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauricio Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.